WallStreetZenWallStreetZen

NASDAQ: MREO
Mereo Biopharma Group PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MREO past revenue growth

How has MREO's revenue growth performed historically?
Company
-87.89%
Industry
73.78%
Market
17.41%
MREO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MREO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MREO earnings and revenue history

Current Revenue
$1.1M
Current Earnings
-$36.9M
Current Profit Margin
-3,384.1%

MREO Return on Equity

Current Company
-48.9%
Current Industry
22.8%
Current Market
33.8%
MREO's Return on Equity (-48.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MREO announces earnings.

MREO Return on Assets

Current Company
-37.5%
Current Industry
3.5%
MREO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MREO Return on Capital Employed

Current Company
-45.58%
Current Industry
21.4%
MREO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MREO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MREO$1.09M-$35.67M-$36.89M-99.20%N/A
EXAI$27.66M-$160.74M-$170.52M+94.29%N/A
HUMA$0.00-$124.85M-$139.66M-100.00%N/A
SRRK$0.00-$195.01M-$203.85M-100.00%N/A
PROK$0.00-$30.40M-$38.68MN/AN/A
View Top Biotech Stocks

Mereo Biopharma Group Earnings & Revenue FAQ

What were MREO's earnings last quarter?

On Invalid Date, Mereo Biopharma Group (NASDAQ: MREO) reported Q2 2024 earnings per share (EPS) of -$0.10, up Infinity% year over year. Total Mereo Biopharma Group earnings for the quarter were -$12.26 million. In the same quarter last year, Mereo Biopharma Group's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Mereo Biopharma Group stock.

What was MREO's earnings growth in the past year?

As of Q3 2024, Mereo Biopharma Group's earnings has grown year over year. Mereo Biopharma Group's earnings in the past year totalled -$36.89 million.

What was MREO's revenue last quarter?

On Invalid Date, Mereo Biopharma Group (NASDAQ: MREO) reported Q2 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Mereo Biopharma Group's revenue was $9.00 million.

What was MREO's revenue growth in the past year?

As of Q3 2024, Mereo Biopharma Group's revenue has grown -87.89% year over year. This is 161.67 percentage points lower than the US Biotechnology industry revenue growth rate of 73.78%. Mereo Biopharma Group's revenue in the past year totalled $1.09 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.